Contrave（肥満治療薬）：市場予測及び分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 14
3.1.1 Etiology 14
3.1.2 Pathophysiology 15
3.1.3 Prognosis 15
3.1.4 Quality of Life 16
3.2 Symptoms 16
4 Disease Management 17
4.1 Treatment Overview 17
5 Competitive Assessment 23
5.1 Overview 23
5.2 Strategic Competitor Assessment 27
6 Opportunity and Unmet Need 29
6.1 Overview 29
6.2 A Drug with Greater Than 10% Average Weight Loss 30
6.2.1 Unmet Need 30
6.2.2 Gap Analysis 31
6.2.3 Opportunity 32
6.3 A Drug with Increased Safety and Tolerability 32
6.3.1 Unmet Need 32
6.3.2 Gap Analysis 33
6.3.3 Opportunity 33
6.4 Reimbursement by Private and Public Payers 33
6.4.1 Unmet Need 33
6.4.2 Gap Analysis 35
6.4.3 Opportunity 35
6.5 Increased Physician Education 35
6.5.1 Unmet Need 35
6.5.2 Gap Analysis 36
6.5.3 Opportunity 36
6.6 Increased Drug-Treatment Rate 37
6.6.1 Unmet Need 37
6.6.2 Gap Analysis 37
6.6.3 Opportunity 38
6.7 Improved Guidelines 38
6.7.1 Unmet Need 38
6.7.2 Gap Analysis 39
6.7.3 Opportunity 39
6.8 Improved Approach to Diagnosis 39
6.8.1 Unmet Need 39
6.8.2 Gap Analysis 40
6.8.3 Opportunity 40
7 Pipeline Assessment 41
7.1 Overview 41
7.2 Promising Drugs in Clinical Development 44
8 Contrave 47
8.1 Overview 47
8.2 Efficacy 48
8.3 Safety 49
8.4 Dosing and Formulation 49
8.5 Potential Clinical Positioning 50
8.6 Potential Commercial Positioning 50
8.7 Pricing and Reimbursement 50
8.8 SWOT Analysis 51
8.9 Forecast 51
9 Appendix 53
9.1 Bibliography 53
9.2 Abbreviations 58
9.3 Research Methodology 59
9.4 Forecasting Methodology 59
9.4.1 Percent Drug-Treated Obesity Patients 60
9.4.2 Key Launch Dates 60
9.4.3 Individual Drug Assumptions 61
9.4.4 Generic Erosion 61
9.5 Physicians, Specialists, and Payers Included in This Study 62
9.6 About the Authors 65
9.6.1 Analysts 65
9.6.2 Therapy Director – CVMD and Infectious Disease 66
9.6.3 Director – Medical Devices 66
9.6.4 Global Head of Healthcare 67
9.7 About GlobalData 68
9.8 Disclaimer 68